Bayer Aktiengesellschaft Share Price Other OTC
Equities
BAYRY
US0727303028
Pharmaceuticals
Sales 2024 * | 47.12B 51.17B 4,027B | Sales 2025 * | 47.89B 52B 4,092B | Capitalization | 28.16B 30.58B 2,407B |
---|---|---|---|---|---|
Net income 2024 * | 2.35B 2.55B 201B | Net income 2025 * | 3.18B 3.46B 272B | EV / Sales 2024 * | 1.29 x |
Net Debt 2024 * | 32.4B 35.18B 2,769B | Net Debt 2025 * | 30.17B 32.76B 2,578B | EV / Sales 2025 * | 1.22 x |
P/E ratio 2024 * |
12.5
x | P/E ratio 2025 * |
8.78
x | Employees | - |
Yield 2024 * |
0.38% | Yield 2025 * |
0.78% | Free-Float | 99.97% |
Latest transcript on Bayer Aktiengesellschaft
Managers | Title | Age | Since |
---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 31/03/23 |
Director of Finance/CFO | 55 | 25/04/18 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 31/03/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 31/03/17 |
Alberto Weisser
BRD | Director/Board Member | 67 | 31/03/21 |
Paul Achleitner
BRD | Director/Board Member | 67 | 31/03/02 |
1st Jan change | Capi. | |
---|---|---|
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |